Literature DB >> 11302831

In vitro activity of clarithromycin against intracellular Helicobacter pylori.

R Piccolomini1, G Di Bonaventura, C Picciani, F Laterza, J Vecchiet, M Neri.   

Abstract

The in vitro intracellular effect of clarithromycin, amoxicillin, metronidazole, lansoprazole, and rifabutin, tested at concentrations corresponding to one times the MIC, two times the MIC, and four times the MIC, was evaluated against an invasive Helicobacter pylori strain. At four times the MIC, clarithromycin showed an early bactericidal effect within 4 h of incubation and, in determining the complete killing within a 16 h-incubation period, lansoprazole and rifabutin showed comparable activity, yielding bactericidal activities within 4 and 8 h of incubation, respectively. Amoxicillin and metronidazole showed bacteriostatic activity only.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302831      PMCID: PMC90509          DOI: 10.1128/AAC.45.5.1568-1571.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin.

Authors:  A Pilotto; M Franceschi; M Rassu; F Furlan; M Scagnelli
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

2.  In-vitro activity of azithromycin in against intracellular Helicobacter pylori.

Authors:  K Hulten; O Cars; E Hjelm; L Engstrand
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

3.  Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens.

Authors:  F Perri; V Festa; R Clemente; M Quitadamo; A Andriulli
Journal:  Aliment Pharmacol Ther       Date:  2000-03       Impact factor: 8.171

4.  Invasiveness of Helicobacter pylori into human gastric mucosa.

Authors:  G H Ko; S M Kang; Y K Kim; J H Lee; C K Park; H S Youn; S C Baik; M J Cho; W K Lee; K H Rhee
Journal:  Helicobacter       Date:  1999-06       Impact factor: 5.753

5.  Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens.

Authors:  R Piccolomini; G Di Bonaventura; D Festi; G Catamo; F Laterza; M Neri
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

6.  Helicobacter pylori entry into human gastric epithelial cells: A potential determinant of virulence, persistence, and treatment failures.

Authors:  B Björkholm; V Zhukhovitsky; C Löfman; K Hultén; H Enroth; M Block; R Rigo; P Falk; L Engstrand
Journal:  Helicobacter       Date:  2000-09       Impact factor: 5.753

7.  Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular?

Authors:  L Engstrand; D Graham; A Scheynius; R M Genta; F El-Zaatari
Journal:  Am J Clin Pathol       Date:  1997-11       Impact factor: 2.493

8.  Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach.

Authors:  M P Dore; G Leandro; G Realdi; A R Sepulveda; D Y Graham
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

9.  Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa.

Authors:  L A Noach; T M Rolf; G N Tytgat
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

10.  Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.

Authors:  C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

View more
  4 in total

1.  Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.

Authors:  Jed W Fahey; Xavier Haristoy; Patrick M Dolan; Thomas W Kensler; Isabelle Scholtus; Katherine K Stephenson; Paul Talalay; Alain Lozniewski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 2.  Rescue Therapy with a Proton Pump Inhibitor Plus Amoxicillin and Rifabutin for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis.

Authors:  Xiaoqun Liu; Hui Wang; Zhifa Lv; Youhua Wang; Ben Wang; Yong Xie; Xiaojiang Zhou; Nonghua Lv
Journal:  Gastroenterol Res Pract       Date:  2015-05-25       Impact factor: 2.260

Review 3.  Rifabutin for the Treatment of Helicobacter Pylori Infection: A Review.

Authors:  Javier P Gisbert
Journal:  Pathogens       Date:  2020-12-28

4.  Proton pump inhibition increases rapid eye movement sleep in the rat.

Authors:  Munazah Fazal Qureshi; Sushil K Jha
Journal:  Biomed Res Int       Date:  2014-02-19       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.